HomeSAGE • NASDAQ
add
SAGE Therapeutics Inc
Previous close
$5.55
Day range
$7.36 - $7.85
Year range
$4.62 - $27.68
Market cap
467.25M USD
Avg Volume
1.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 11.87M | 337.08% |
Operating expense | 58.70M | -30.95% |
Net income | -93.55M | 53.60% |
Net profit margin | -788.06 | 89.38% |
Earnings per share | -1.53 | 45.45% |
EBITDA | -100.95M | 43.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 569.15M | -35.03% |
Total assets | 622.43M | -34.46% |
Total liabilities | 70.60M | -46.92% |
Total equity | 551.84M | — |
Shares outstanding | 61.17M | — |
Price to book | 0.62 | — |
Return on assets | -38.35% | — |
Return on capital | -42.47% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -93.55M | 53.60% |
Cash from operations | -82.36M | 39.38% |
Cash from investing | 81.05M | -49.47% |
Cash from financing | 1.04M | -62.56% |
Net change in cash | -274.00K | -101.00% |
Free cash flow | -51.91M | -24.90% |
About
Founded
2010
Website
Employees
487
